- Methyl (16E)-9-methoxy-16-(methoxymethylidene)coryn-18-en-17-oate
- Methyl (2E)-2-(3-ethenyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate
Hassan, Z; Muzaimi, M; Navaratnam, V; Yusoff, NHM; Suhaimi, FW; Vadivelu, R; Vicknasingam, BK; Amato, D; von Hörsten, S; Ismail, NIW; Jayabalan, N; Hazim, AI; Mansor, SM; Müller, CP. From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction Neurosci. Biobehav. Rev., 1 Feb 2013, 37 (2), 138–151. 602 kB. https://doi.org/10.1016/j.neubiorev.2012.11.012
Warner, ML; Kaufman, NC; Grundmann, O. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse Int. J. Legal Med., 1 Jan 2016, 130 (1), 127-138. 811 kB. https://doi.org/10.1007/s00414-015-1279-y
Maurer, HH. Chemistry, pharmacology, and metabolism of emerging drugs of abuse Ther. Drug Monit., 1 Oct 2010, 32 (5), 544–549. 142 kB. https://doi.org/10.1097/FTD.0b013e3181eea318 #Paynantheine
Sharma, A; Kamble, SH; León, F; Chear, NJ; King, TI; Berthold, EC; Ramanathan, S; McCurdy, CR; Avery, BA. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography—tandem mass spectrometry Drug Test. Anal., 17 Apr 2019, 11 (8), 1162-1171. 830 kB. https://doi.org/10.1002/dta.2604 #Paynantheine LC,MS